We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published On : Apr 2023
  • Code : CMI2711
  • Pages :170
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic

The global western blotting market is estimated to be valued at US$ 759.5 million in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Analysts’ Views on Global Western Blotting Market:

Use of western blotting for medical diagnosis is expected to drive the global western blotting market over the forecast period. For instance, in April 2021, according to National Center for Biotechnology Information (NCBI), western blotting has been widely used in disease diagnosis mostly for the detection of HIV.

Figure 1. Global Western Blotting Market Share (%), by Application, 2023

WESTERN BLOTTING MARKET

To learn more about this report, request a free sample copy

Global Western Blotting Market – Driver

Increasing prevalence of HIV  

Increasing prevalence of HIV is expected to drive the global western blotting market over the forecast period as western blotting is mostly used for detection of HIV. For instance, in January 2022, according to data published by UNAIDS, a Joint United Nations Programme which is involved in data collection on HIV epidemiology, 1.5 million people became newly infected with HIV in 2021.

Figure 2. Global Western Blotting Market Value (US$ Million), by Region, 2023

WESTERN BLOTTING MARKET

To learn more about this report, request a free sample copy

Global Western Blotting Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global western blotting market over the forecast period. North America holds 45.1% of the market share due to the increasing prevalence of HIV in the region. For instance, in October 2022, according to the U.S. Department of Health & Human Services, approximately 1.2 million people in the U.S. have HIV and about 13 % of them don’t know if they are suffering from HIV and need testing.

Global Western Blotting Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global western blotting market as western blotting was widely used during the pandemic. For instance, in December 2020, Science Direct, a scientific journal, stated that Western blots were used to identify antigens that could form the basis for developing a COVID-19 vaccine.

Global Western Blotting Market Segmentation:

The global western blotting market report is segmented into product type, application, end user, and region

Based on Product Type, the market is segmented into electrophoresis blotting systems (automated dry blotting systems, semi-dry blotting systems, traditional wet transfer blotting systems), reagents & kits (chromogenic reagents kits, chemiluminescent reagents kits)(horseradish peroxidase (hrp) substrate, alkaline phosphatase (ap) substrate), fluorescent reagents, antibodies(primary antibody, secondary antibody), buffer kits, transfer membranes). Out of which, the electrophoresis blotting systems segment is expected to hold a dominant position in the western blotting market during the forecast period and this is attributed to the increasing usage of electrophoresis blotting systems for the diagnosis of diseases.

Based on Application, the market is segmented into scientific research, medical diagnostics, agricultural application, food & beverages, and other applications. Out of which, the medical diagnostics segment is expected to hold a dominant position in the western blotting market during the forecast period and this is attributed to the increasing prevalence of HIV.

Based on End User, the market is segmented into diagnostic laboratories, research institutions, and pharmaceutical & biotechnology companies. Out of which, diagnostic laboratories is expected to dominate the market over the forecast period and this is attributed to the increase in the number of diagnoses for the identification of infections like HIV.

Among all segmentation, the application segment has the highest potential due to the increasing prevalence of HIV over the forecast period. For instance, in 2022, according to data published by the Centers for Disease Control and Prevention (CDC), stated that in 2020, 30,635 people received an HIV diagnosis in the U.S.

Western Blotting Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 759.5 Mn
Historical Data for: 2017 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 6.8% 2030 Value Projection: US$ 1,204.9 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Electrophoresis Blotting Systems (Automated Dry Blotting Systems, Semi-Dry Blotting Systems, Traditional Wet Transfer Blotting Systems), Reagents & Kits (Chromogenic Reagents Kits, Chemiluminescent Reagents Kits (Horseradish Peroxidase (HRP) Substrate, Alkaline Phosphatase (AP) Substrate), Fluorescent Reagents, Antibodies (Primary Antibody, Secondary Antibody), Buffer Kits), Transfer Membranes)
  • By Application: Scientific Research, Medical Diagnostics, Agricultural Application, Food & Beverages, Other Applications
  • By End User: Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies
Companies covered:

Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies

Growth Drivers:
  • Increasing prevalence of HIV
Restraints & Challenges:
  • Disadvantages associated with western blotting

Global Western Blotting Market Cross Sectional Analysis:

In application segment, medical diagnostics hold a dominant segment in North America region due to the increasing prevalence of HIV and hepatitis C. For instance, in August 2022, according to the Centers for Disease Control and Prevention (CDC), there were 107,300 cases of newly reported chronic hepatitis C in 2020.

Global Western Blotting Market: Key Developments

  • Effective use of western blotting to support effective disease diagnosis is expected to drive the global western blotting market growth over the forecast period. For instance, in May 2021, according to Healthline Media LLC., a consumer health publisher, western blotting is used to confirm or disprove the results of an earlier test for HIV or Lyme disease
  • On January 11, 2023, Azure Biosystems Inc., a developer of monitoring and diagnostic equipment and technologies, announced the launch of the chemiSOLO, a high-performance, personal chemiluminescent imaging system that is compact in size and economical in cost.
  • On February 14, 2023, Bio-Techne, a supplier of tools for life science research, and Cell Signaling Technology, Inc., a company that develops and produces antibodies, kits and reagents, announced the addition of simple western validation to cell signaling technology (CST) antibodies. This will allow researchers in various disciplines an easier way to study important molecular signaling pathways on a trusted and validated platform.

Global Western Blotting Market: Key Trends

Increasing applications of western blotting technique

Increasing applications of western blotting technique is expected to drive the western blotting market growth over the forecast period. For instance, in January 2020, researchers at British Antarctic Survey, Natural Environment Research Council, U.K., reported the use of western blotting in the assessment of post-translationally deiminated protein and EV profiles of plasma in seabird species from the Antarctic.

Global Western Blotting Market: Restraint

Disadvantages associated with western blotting

The global western blotting market can be hindered by disadvantages associated with western blotting. For instance, in April 2022, a report published by National Center for Biotechnology Information (NCBI), stated that disadvantages of western blotting such as poor membrane blocking, excessive antibody concentration, and a dry membrane can result in high background signals.

Global Western Blotting Market - Key Players

Major players operating in the global western blotting market include Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., and Leinco Technologies

*Defination- Western blot is often used in research to separate and identify proteins. In this technique a mixture of proteins is separated based on molecular weight, and thus by type, through gel electrophoresis. These results are then transferred to a membrane producing a band for each protein.

Frequently Asked Questions

The global western blotting market is estimated to be valued at US$ 759.5 million in 2023 and is expected to exhibit a CAGR of 6.8% between 2023 and 2030.

Increasing prevalence of HIV is expected to drive the market growth.

Medical diagnostics is the leading application segment in the market.

Disadvantages associated with western blotting is expected to hinder the market.

Major players operating in the market include Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo